Zinbryta Lawsuit
Amid reports of severe brain inflammation and deaths linked to side effects of Zinbryta, the multiple sclerosis drug was recalled globally in early March 2018. As a result of the drug makers failure to warn about the risk of encephalitis, meningoencephalitis and other problems, Zinbryta lawsuits are being evaluated by product liability lawyers.
STATUS OF ZINBRYTA LAWSUITS: Lawyers are evaluating whether financial compensation may be available for individuals who have experienced any of the following complications following use of Zinbryta:
- Encephalitis
- Meningoencephalitis
- Other Sudden Brain Inflammation
- Wrongful Death
>>SUBMIT INFO TO A ZINBRYTA LAWYER<<
MANUFACTURERS: AbbVie, Inc. and Biogen, Inc.
ZINBRYTA RECALL: Zinbryta (daclizumab) is a multiple sclerosis injection drug that was introduced in 2016, for the treatment of adult patients with relapsing forms of multiple sclerosis.
Due to a risk of liver injury linked to Zinbryta side effects, the drug was only available through to a Risk Evaluation and Mitigation Strategy (REMS) program in the U.S., and regulators only recommended it as a treatment for individuals who have failed to respond to other first-line MS drugs due to severe liver toxicity risks.
Less than two years after the drug was introduced, a worldwide Zinbryta recall was announced in March 2018, following at least 12 reported cases of Zinbryta encephalitis and meningoencephalitis, which causes swelling and inflammation in the brain. At least three of those brain problems on Zinbryta resulted in death, with each of those instances occurring in the United States.
The decision to remove Zinbryta from the market came after an investigation by the European Medicines Agency (EMA), which recommended a ban for the drug across the European Union due to the Zinbryta problems.
About 8,000 individuals worldwide were prescribed Zinbryta before the recall.
Potential symptoms of brain problems from Zinbryta may include:
- Persistent Fever
- Severe Headaches
- Nausea
- Fatigue
- Yellowing of Skin or Eyes
ZINBRYTA LAWYERS: Product liability lawyers are now reviewing whether individuals throughout the United States may be entitled to financial compensation through a Zinbryta brain injury lawsuits or Zinbryta wrongful death lawsuits, as a result of the drug makers’ failure to adequately research the medication and warn about potential side effects.
2 comments
I have suffered from skin lesions, rashes, exema, hair loss, fatigue, severe headaches, and depression. After being on the drug for 3 months, I told my doctor that I wanted to off of it because it wasn’t helping and I didn’t like the fact that I had to have my blood drawn before I could inject each month…made me nervous. He said “No that I had to stay in it”. I can’t believe that I was one of 8,000 people in the world to be out in it. Makes me suspicious of doctors who did put there patients on it….especially when the patient wanted to stop the medication. A little incentive from the drug company? I am seeing a new neurologist and she refused to put any of her patients on it.
My experience was acute respiratory failure with full body skin rash, alopecia. Recovery with oxygen therapy for 5 months and follow up with pulmonologist for next two years. Continued prednisone now at 8 months. appt next week with Pulmonologist to review CT scan for permanent damage.